Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald N Jones

Showing results (71-80 of 662) with videos related to

Pageof 67
Sort By:
Antimicrobial Agents and Chemotherapy|February 24, 2010
CEM-101 activity against Gram-positive organismsLeah N Woosley, Mariana Castanheira, Ronald N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment optionsMariana Castanheira, Rodrigo E Mendes, Ronald N Jones
Journal of Clinical Microbiology|August 9, 2003
Commercial broth microdilution panel validation and reproducibility trials for garenoxacin (BMS-284756), a novel desfluoroquinoloneKelley A Gordon, Paul R Rhomberg, Ronald N Jones
The Journal of Antimicrobial Chemotherapy|July 19, 2006
Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapyPaul G Mariani, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)Ronald N Jones, Helio S Sader, Thomas R Fritsche
Journal of Clinical Microbiology|February 8, 2005
Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methodsRonald N Jones, Tamara R Anderegg, Jana M Swenson, et al.
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)Ronald N Jones, Helio S Sader, Thomas R Fritsche
International Journal of Antimicrobial Agents|March 12, 2004
Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptideRonald N Jones, Jennifer M Streit, Thomas R Fritsche
Journal of Clinical Microbiology|June 10, 2011
Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinoloneJames E Ross, Lisa C Liverman, Ronald N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 22, 2008
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patientsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Pageof 67

Showing results (71-80 of 662) with videos related to

Sort By:
Pageof 67
Antimicrobial Agents and Chemotherapy|February 24, 2010
CEM-101 activity against Gram-positive organismsLeah N Woosley, Mariana Castanheira, Ronald N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment optionsMariana Castanheira, Rodrigo E Mendes, Ronald N Jones
Journal of Clinical Microbiology|August 9, 2003
Commercial broth microdilution panel validation and reproducibility trials for garenoxacin (BMS-284756), a novel desfluoroquinoloneKelley A Gordon, Paul R Rhomberg, Ronald N Jones
The Journal of Antimicrobial Chemotherapy|July 19, 2006
Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapyPaul G Mariani, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)Ronald N Jones, Helio S Sader, Thomas R Fritsche
Journal of Clinical Microbiology|February 8, 2005
Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methodsRonald N Jones, Tamara R Anderegg, Jana M Swenson, et al.
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)Ronald N Jones, Helio S Sader, Thomas R Fritsche
International Journal of Antimicrobial Agents|March 12, 2004
Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptideRonald N Jones, Jennifer M Streit, Thomas R Fritsche
Journal of Clinical Microbiology|June 10, 2011
Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinoloneJames E Ross, Lisa C Liverman, Ronald N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 22, 2008
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patientsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Pageof 67